Shares of Clovis Oncology, Inc. (NASDAQ:CLVS) have seen a consistent move higher lately. The stock has reached the $50.86 mark after a recent check. This move has generated increased interest from both analysts and investors.
Share Performance Summary
Since the start of the calendar year, Clovis Oncology, Inc. (NASDAQ:CLVS)’s stock has changed 14.50%. Over the last five trading sessions, the stock has moved 14.50%. For the past month, Clovis Oncology, Inc.’s stock has been 32.41%, 72.93% for the last quarter, 245.99% for the past six months and 74.36% for the past 52 weeks.
Based on current stock levels, Clovis Oncology, Inc. shares are trading 8.28% off of the 50-day high and 97.06% away from the 50-day low.
Earnings Per Share (EPS), the portion of a company’s profit distributed to each outstanding common share, is a useful indicator of a company’s profitability. EPS is typically considered to be the most important variable in determining a share’s price. Clovis Oncology, Inc. (NASDAQ:CLVS)’s EPS growth this year is -107.40% and the trailing 12-month EPS is $-10.37. Covering sell-side analysts are estimating company growth for next year to be 46.70%. On a consensus basis, analysts have given a recommendation of 2.60 on company shares.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.